HSPOF
Horizon Space Acquisition I Corp.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- TrendUPTREND
2% above its 50-day average.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
2 filings · 1 bullish · 0 bearish · 1 neutral- NEUTRAL 425Oct 13, 2026
Horizon Space Acquisition I Corp. (HSPO) has entered into a definitive business combination…
The $2.0B valuation for a pre-revenue clinical-stage biotech with only a Phase I psoriasis trial is aggressive relative to comparable SPAC targets. Monitor the proxy statement for ArcheNova's…
- BULLISH 8-KOct 13, 2026
Horizon Space Acquisition I Corp. (HSPOF) has entered into a definitive business combination…
The definitive agreement provides a clear path to closing. Key catalysts to watch: (1) SEC review of the F-4 registration statement, (2) shareholder votes for both SPAC and ArcheNova, and (3) Nasdaq…
All HSPOF filing & press-release reports (2)
- 425 reportOct 13, 2026
- 8-K reportOct 13, 2026